Methotrexate assay by enzymatic inhibition, with use of centrifugal analyzer.
- 1 November 1977
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 23 (11) , 2139-2141
- https://doi.org/10.1093/clinchem/23.11.2139
Abstract
We present a method for measuring methotrexate by enzymatic inhibition, with use of the centrifugal analyzer. In the presence of dihydrofolate reductase (EC 1.5.1.3), dihydrofolic acid is converted to tetrahydrofolate. NADPH acts as a coenzyme. Methotrexate inhibits the action of dihydrofolate reductase. Increasing concentrations of methotrexate depress the conversion of NADPH to NADP+, and the reaction may be followed at 340 nm. Precision, accuracy, and sensitivity are satisfactory. A comparison to the radioimmunoassay method (x) showed the following least-squares regression: y = 0.9813x + 5.6 microgram/liter; r = .9812; Sy = 6.3 microgram/liter. Some interference was noted from bilirubin, lipermia, and hemoglobin. Up to 60 patients' samples per hour may be estimated by this technique.This publication has 4 references indexed in Scilit:
- Assay of Phenobarbital: Adaptation of "EMIT" to the Centrifugal AnalyzerClinical Chemistry, 1977
- Methotrexate in blood, urine, and cerebrospinal fluid of children receiving high doses by infusion.Clinical Chemistry, 1976
- Assay of phenytoin: adaptation of "EMIT" to the centrifugal analyzer.Clinical Chemistry, 1976
- Enzymatic assay for methotrexate in serum and cerebrospinal fluid.Clinical Chemistry, 1976